APLT CEO Shendelman sold 777.0K shares for $4.7M across 3 days; now holds 4.69M shares (was 5.47M).
Shoshana Shendelman, President and CEO of Applied Therapeutics, executed 3 separate sales totaling 777,014 shares for $4,712,048.77 over August 12-14, 2024, at a blended average price of $6.06, reducing her holdings by 14.2% from 5,467,853 to 4,690,839 shares. At her cross-ticker track record, her prior sells have been well-timed 100.00% of the time with an average 90-day return of -2.2%, suggesting a demonstrated ability to sell ahead of downside moves. However, her single prior sale at APLT on 2024-03-14 showed a 90-day return of -2.2%, a well-timed outcome at that ticker. The current stock price of $5.92 is down 20.0% from the 52-week high of $7.40 and sits just below her blended sale price of $6.06, placing the sale near peak recent valuations. Notably, the company faces ongoing operational headwinds: latest-quarter revenue was $144,000.00 while net income sits at $2,898,000.00, and the company remains unprofitable on a full-year basis, suggesting potential vulnerability despite the 39.3% 90-day appreciation preceding this sale.